Citi analyst Joanne Wuensch lowered the firm’s price target on GE HealthCare (GEHC) to $86 from $105 and keeps a Buy rating on the shares following Q1 results. The firm noted that GE HealthCare is one of the companies “most negatively impacted” by tariffs. However, Citi believes the underlying business “appears strong” and that key products are intact. GE Healthcare has a “long funnel” of mitigation opportunities that will depend on finalized tariff rates, according to the firm.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Resilient Growth Amidst Challenges: Buy Rating for GE Healthcare Technologies Inc.
- GE HealthCare price target lowered to $82 from $95 at BTIG
- Early notable gainers among liquid option names on April 30th
- Morning Movers: Norwegian Cruise Line falls following first quarter results
- GE HealthCare reports Q1 adjusted EPS $1.01, consensus 91c